Royce & Associates’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-9,200
Closed -$522K 908
2023
Q4
$522K Buy
+9,200
New +$522K ﹤0.01% 789
2022
Q4
Sell
-5,134
Closed -$260K 935
2022
Q3
$260K Sell
5,134
-3,737
-42% -$189K ﹤0.01% 875
2022
Q2
$404K Buy
8,871
+114
+1% +$5.19K ﹤0.01% 856
2022
Q1
$407K Buy
+8,757
New +$407K ﹤0.01% 899
2021
Q2
Sell
-14,620
Closed -$713K 1027
2021
Q1
$713K Sell
14,620
-5,020
-26% -$245K ﹤0.01% 892
2020
Q4
$795K Buy
19,640
+4,216
+27% +$171K 0.01% 837
2020
Q3
$502K Buy
15,424
+5,368
+53% +$175K 0.01% 861
2020
Q2
$265K Buy
10,056
+4,027
+67% +$106K ﹤0.01% 912
2020
Q1
$150K Buy
6,029
+83
+1% +$2.07K ﹤0.01% 949
2019
Q4
$214K Sell
5,946
-64
-1% -$2.3K ﹤0.01% 966
2019
Q3
$205K Buy
6,010
+199
+3% +$6.79K ﹤0.01% 975
2019
Q2
$163K Buy
5,811
+40
+0.7% +$1.12K ﹤0.01% 997
2019
Q1
$179K Sell
5,771
-75,876
-93% -$2.35M ﹤0.01% 1001
2018
Q4
$1.93M Buy
81,647
+14,009
+21% +$331K 0.02% 741
2018
Q3
$2.62M Sell
67,638
-15,736
-19% -$610K 0.02% 771
2018
Q2
$2.79M Buy
83,374
+39,683
+91% +$1.33M 0.02% 755
2018
Q1
$1.58M Buy
43,691
+38,471
+737% +$1.39M 0.01% 893
2017
Q4
$166K Buy
5,220
+51
+1% +$1.62K ﹤0.01% 1091
2017
Q3
$193K Buy
5,169
+169
+3% +$6.31K ﹤0.01% 1072
2017
Q2
$156K Buy
+5,000
New +$156K ﹤0.01% 1084
2015
Q4
Sell
-9,900
Closed -$121K 1150
2015
Q3
$121K Hold
9,900
﹤0.01% 1121
2015
Q2
$119K Hold
9,900
﹤0.01% 1148
2015
Q1
$83K Buy
+9,900
New +$83K ﹤0.01% 1167